Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
Donavan T. Cheng(Memorial Sloan Kettering Cancer Center), Talia Mitchell(Memorial Sloan Kettering Cancer Center), Ahmet Zehir(Memorial Sloan Kettering Cancer Center), Ronak Shah(Memorial Sloan Kettering Cancer Center), Ryma Benayed(Memorial Sloan Kettering Cancer Center), Aijazuddin Syed(Memorial Sloan Kettering Cancer Center), Raghu Chandramohan(Memorial Sloan Kettering Cancer Center), Zhen Yu Liu(Memorial Sloan Kettering Cancer Center), Helen Won(Memorial Sloan Kettering Cancer Center), Sasinya N. Scott(Memorial Sloan Kettering Cancer Center), A. Rose Brannon(Memorial Sloan Kettering Cancer Center), Catherine O’Reilly(Memorial Sloan Kettering Cancer Center), Justyna Sadowska(Memorial Sloan Kettering Cancer Center), Jacklyn Casanova(Memorial Sloan Kettering Cancer Center), Angela Yannes(Memorial Sloan Kettering Cancer Center), Jaclyn F. Hechtman(Memorial Sloan Kettering Cancer Center), JinJuan Yao(Memorial Sloan Kettering Cancer Center), Wei Song(Memorial Sloan Kettering Cancer Center), Dara S. Ross(Memorial Sloan Kettering Cancer Center), Alifya Oultache(Memorial Sloan Kettering Cancer Center), Snjezana Doğan(Memorial Sloan Kettering Cancer Center), Laetitia Borsu(Memorial Sloan Kettering Cancer Center), Meera Hameed(Memorial Sloan Kettering Cancer Center), Khédoudja Nafa(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center)
Cited by 2,141